承德露露(000848.SZ):擬更名為“承德露露股份公司”
格隆匯4月11日丨承德露露(000848.SZ)公佈,公司於2022年4月8日召開第八屆董事會第八次會議,審議通過了公司《關於擬變更公司名稱的議案》。原公司全稱:河北承德露露股份有限公司;變更後公司全稱:承德露露股份公司(以工商管理部門最終核准為準)。
公司名稱擬變更原因:公司依託承德當地豐富的山杏仁資源,在二十世紀七十年代開發生產了擁有自主知識產權的植物蛋白飲料——杏仁露,目前的主營業務為植物蛋白飲料的生產和銷售。此次擬變更公司名稱,是根據公司發展需要,對公司名稱進行精簡、提煉,進一步凸顯公司品牌價值,強化品牌認知,與公司發展規劃相匹配,有助於提升公司品牌形象和市場影響力,推動公司高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.